Immune response to the BNT162b2 vaccine against the COVID-19 virus in healthcare workers and immunocompromised patients

Not Applicable

Completed

• Conditions: COVID-19 (SARS-CoV-2 infection) in health-care-workers and oncological/immunocompromised patients; Infections and Infestations; COVID-19 (SARS-CoV-2 infection)

• Registration Number: ISRCTN55371988
• Lead Sponsor: Istituti Fisioterapici Ospitalieri

Brief Summary

2021 Other publications in https://doi.org/10.3390/vaccines9070685 Correlation with age, gender and BMI (added 05/08/2021) 2021 Other publications in https://doi.org/10.1016/j.eclinm.2021.100928 Effect of age, gender and BMI on vaccine response (added 05/08/2021) 2021 Results article in https://doi.org/10.3390/vaccines9101125 (added 06/03/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-24
• Study Completion: 2023-02-23
• Last Update Posted: 18 March 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Provided written informed consent
2. Oncological/immunocompromised patient at the Istituti Fisioterapici Ospitalieri (IFO) or health worker employed at the Istituti Fisioterapici Ospitalieri
3. Vaccinated at the Istituti Fisioterapici Ospitalieri

Exclusion Criteria

1. Evidence of current or previous SARS-CoV-2 infection by either anamnesis, serological or microbiological test through nasopharyngeal swab before enrolment

Study & Design

• Study Type: Observational
• Study Design: Not specified